Cargando…
SMARCA4‐deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report
Thoracic SMARCA4‐deficient undifferentiated tumors are a new type of neoplasm that commonly occur in the mediastinum, progress rapidly, and show a poorer prognosis. We report a case of thoracic SMARCA4‐deficient undifferentiated tumor in the right thoracic cavity in a patient with a history of heavy...
Autores principales: | Utsumi, Takahiro, Taniguchi, Yohei, Noda, Yuri, Fukai, Mari, Kibata, Kayoko, Murakawa, Tomohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346173/ https://www.ncbi.nlm.nih.gov/pubmed/35778998 http://dx.doi.org/10.1111/1759-7714.14547 |
Ejemplares similares
-
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
por: Lin, Ying, et al.
Publicado: (2023) -
Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023) -
Case Series of SMARCA4-Deficient Undifferentiated Esophageal Carcinoma
por: Ahmed, Omar T, et al.
Publicado: (2022) -
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022) -
SMARCA4-deficient undifferentiated thoracic tumor: A case report
por: Kwon, Hee Jung, et al.
Publicado: (2023)